Pharma Journalist -

SAE Media Group reports: The 2nd Annual Oligonucleotide Therapeutics & Delivery Conference is set to return in September 2022 with a key focus on advancements in extra-hepatic…
Read More...

Assessing device development and regulation for advanced innovation SAE Media Group’s 6th Annual Conference Pre-Filled Syringes West Coast June 13 - 14, 2022 | San Diego, CA, USA…
Read More...

Eiger Biopharmaceuticals Inc. and AnGes Inc. announced that the companies entered into an agreement for the regulatory approval, marketing, and distribution of Zokinvy (lonafarnib) for…
Read More...

MOMA Therapeutics, a biopharmaceutical company discovering the next generation of precision medicines by targeting molecular machines that underlie human disease, announced the…
Read More...

Thermo Fisher Scientific today launched a new collection of qPCR biopharma offerings to help accelerate drug development to meet a growing demand for novel biologics. The QualTrak…
Read More...

Pfizer Inc. and Biohaven Pharmaceutical Holding Company Ltd. announced that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven, the maker of…
Read More...

Hitachi High-Tech Corporation has entered into a strategic partnership (the Partnership) with Invivoscribe, Inc. ("Invivoscribe"), a global provider of blood cancer testing kits and…
Read More...

Twist Bioscience Corporation a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced it has entered into a…
Read More...

GNS Healthcare, the leader in the use of "Virtual Patients", Causal AI and simulation technology for biopharmaceutical companies, announced a collaboration with Arvinas, Inc. a…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the termination of its collaboration and license agreements with Bavarian Nordic that leverage Bavarian…
Read More...